Showing results (1211-1220 of 1,359) with videos related to
Sort By:
Pageof 136
Haemostasis|January 1, 1990
Coagulation disturbances in cancer of the breast and colon measured with specific monoclonal antibody enzyme immunoassay for fibrin-fibrinogen degradation productsP McCulloch, W Nieuwenhuizen, J Douglas, et al.Haemostasis|January 1, 1989
Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivativesJ Harenberg, C Giese, A Knödler, et al.Haemostasis|January 1, 1989
Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgeryM Dechavanne, D Ville, M Berruyer, et al.Haemostasis|February 22, 2001
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interactionY Ikeda, M Handa, M Murata, et al.Haemostasis|March 24, 1999
Low-dose vitamin K1 versus short-term with holding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol. A retrospective comparative studyM Ortín, J Olalla, F Marco, et al.Haemostasis|March 24, 1999
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use programS Arkin, H A Cooper, J J Hutter, et al.Haemostasis|March 24, 1999
Influence of HIV-infection on the Karnofsky score and general social functioning in patients with hemophiliaT Wenzel, G Pindur, S Mörsdorf, et al.Haemostasis|March 17, 2001
Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?M GalliHaemostasis|March 17, 2001
Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factorH M Otten, M H Prins, S M Smorenburg, et al.Haemostasis|March 17, 2001
Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean?A T Cohen, A KhushalPageof 136